Filing Details

Accession Number:
0001593968-20-001750
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-14 16:13:54
Reporting Period:
2020-08-12
Accepted Time:
2020-08-14 16:13:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1177917 Edmund Harrigan C/O Karuna Therapeutics, Inc.
33 Arch St Ste 3110
Boston MA 02110-1424
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-12 10,000 $83.32 55,163 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.